Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis

NCT00111514 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Leishmaniasis, Mucocutaneous

Interventions

BIOLOGICAL: Leish-111f + MPL-SE vaccine

Sponsor

Access to Advanced Health Institute (AAHI)

Collaborators

[object Object]